Filing Flows › Nu Skin Enterprises (NUS) › Q2 2026 › vs Q2 2025
Nu Skin Enterprises (NUS) Q2 2026 vs Q2 2025 (year over year)
Nu Skin Enterprises's revenue fell $66.0M (-17%) from $386M in Q2 2025 to $320M in Q2 2026.
Nu Skin Enterprises, Q2 2026: revenue $320M (-17% year over year), operating margin -18.5%, net loss $250M, operating cash flow $10.6M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 1.6% | 9.3% | -7.7 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $320M | $386M | −$66.0M | -17% |
| Net loss | $250M | −$21.1M | $271M | — |
| Costs & expenses | $570M | $386M | $184M | +48% |
| Operating costs | $379M | $355M | $24.1M | +7% |
| Interest & other, net | $3.9M | $3.4M | $487K | +14% |
| Income tax | $187M | $6.3M | $180M | 30× |
| Cost of revenue | $102M | $120M | −$18.6M | -15% |
| Sales & marketing | $108M | $128M | −$20.3M | -16% |
| General & admin | $90.8M | $107M | −$15.9M | -15% |
| Operating cash sources | $260M | $14.7M | $246M | 18× |
| Depreciation & amortization | $12.7M | $13.1M | −$394K | -3% |
| Share-based compensation | $1.1M | $5.8M | −$4.7M | -81% |
| Working capital & other | $247M | −$4.2M | $251M | — |
| Net loss absorbed | $250M | −$21.1M | $271M | — |
| Operating cash flow | $10.6M | $35.8M | −$25.2M | -70% |
| Free cash flow (OCF − capex) | $5.0M | $35.8M | −$30.8M | -86% |
| Capital expenditures | $5.6M | $18K | $5.6M | 313× |
Questions
How much did Nu Skin Enterprises's revenue grow year over year in Q2 2026?
Nu Skin Enterprises's revenue fell $66.0M (-17%) from $386M in Q2 2025 to $320M in Q2 2026.